Mushrooms (MSRM) Stock Price, News & Analysis
Company Description
Mushrooms Inc. (MSRM) develops biotechnology and health-related products based on mushrooms, mycelium, and mycelium-derived materials. The company is an OTC-traded operating company focused on mushroom-based wellness products and research programs that apply mycelium to healthcare and textile uses.
The company’s commercial health-and-wellness products include LONGEVITY and SPORT+, mushroom-based supplements positioned around wellness, healthy aging, athletic performance, energy, endurance, and recovery. Mushrooms Inc. has described distribution through online, retail, and wholesale channels.
Mushrooms Inc. also works on mycelium material technologies. Its technology disclosures include MYCO Thread, a nutrient-delivery textile concept tied to the company’s non-provisional patent application titled METHOD OF GENERATING MULTIFUNCTIONAL MYCELIUM PRODUCTS. The company has described potential applications for mycelium-based textiles, including biodegradable thread, nutrient-rich fabrics, athletic wear, bedding, everyday clothing, and protective materials.
A separate development focus involves mycelium-based healthcare materials for bacterial detection. Mushrooms Inc. has described a bacterial detection bandage concept intended to use mycelium-based materials to identify bacterial presence and support nutrient delivery. This places the company’s research activity at the intersection of mushroom biotechnology, sustainable materials, health supplements, and healthcare-oriented product development.
As a small public issuer, Mushrooms Inc.’s public updates have also covered governance, shareholder voting matters, capital-structure topics, strategic initiatives, business development activity, patent-related technology development, and operating and financial results.
Stock Performance
Mushrooms (MSRM) stock last closed at $0.0162. Over the past 12 months, the stock has lost 18.2%. At a market capitalization of $728.1K, MSRM is classified as a micro-cap stock with approximately 44.9M shares outstanding.
Latest News
Mushrooms has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, partnership. View all MSRM news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Mushrooms (MSRM) currently stands at 1.4 thousand shares, down 45.1% from the previous reporting period, representing 0.0% of the float. Since September 2025, short interest has decreased by 97.0%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Mushrooms (MSRM) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 42.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.8 days.
MSRM Company Profile & Sector Positioning
Mushrooms (MSRM) operates in the Farm Products industry within the broader Consumer Defensive sector and is listed on the OTC Link.
Investors comparing MSRM often look at related companies in the same sector, including Glg Life Tech (GLGLF), Naturalshrimp (SHMP), 10X Cap Venture Acqstn Corp Ii (AAGR), Atlantic Sapphir (AASZF), and Skinvisible (SKVI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MSRM's relative position within its industry.